Use of Skindex-29 to assess quality of life in patients with port-wine stain


  • Talat Masood Akbar
  • Haroon Nabi
  • Mahmood A. Saqib
  • Hamdah Aftab
  • Hira Khalil
  • Sobia Khakwani
  • Izza Raza Sahi


Port-wine stain (PWS), quality of life, Skindex-29


Objective To determine the effect of facial port-wine stain (PWS) on quality of life (QoL) in our population with skin type III to IV, using the Skindex-29Ó scoring system. Methods A total number of 69 patients were enrolled in this study. Patients were examined clinically and demographic data was collected. Patients were provided with Skindex-29Ó questionnaire with three independent domains affecting patient emotions, symptoms and functioning. Questionnaire had to be completed by patients themselves or with the help of an interpreter. The specific scoring system was used with a scale from 1-100; higher score indicated a greater impact of skin disease. Results Facial PWS had a moderately negative impact on QoL of the patient. Subscores calculated for symptoms were 8.17±6.70, emotions 25.72±7.83, and functions 21.00±11.34. Composite score was 19.53±11.26. These scores indicate that the greatest negative effect was on emotions, followed by functions and then symptoms. There was no significant difference in scores between the sexes. A greater area of involvement was significantly associated with higher emotional (p=0.04) and symptoms score (p=0.003).  Deeper colour of PWS was associated with more symptoms (p=0.01). Conclusion Our study indicates that facial PWS has negative impact on a patient’s QoL, having more affect on emotions, followed by functions. Males and females were equally affected in all domains by PWS. Impact on emotions and symptoms is directly proportional to the size of PWS. 


Faurschou A, Togsverd-Bo K, Zachariae C, Hædersdal M. Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation. Br J Dermatol. 2009;160:359-64.

Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58:218-22.

Brauer JA, Geronemus RG. Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol. 2013:16:51-4.

Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. 1991;17:76-9.

Minkis K, Geronemus RG, Hale EK. Port wine stain progression: a potential consequence of delayed and inadequate treatment? Lasers Surg Med. 2009;41:423-6.

Brightman LA, Geronemus RG, Reddy KK. Laser treatment of port-wine stains. Clin Cosmet Investig Dermatol. 2015;8:27-33.

Hagen SL, Grey KR, Korta DZ, Kelly KM. Quality of life in adults with facial port-wine stains. J Am Acad Dermatol. 2017;76:695-702.

Finlay AY. Quality of life in dermatology: After 125 years, time for more rigorous reporting. Br J Dermatol. 2014;170:4-6.

Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol. 1987;12:8-11.

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol.1994; 19: 210-216.

Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17:1-3.

Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60: 984-92.

Doward LC, McKenna SP. Evolution of quality of life assessment. In: Rajagopalan R, Sheretz EF, Anderson TR, eds. Care Management of Skin Diseases, 1st edn. New York: Marcell-Dekker; 1998. P. 9-94.

Higginson IJ, Carr AJ. Using quality of life measures in the clinical setting. BMJ. 2001;322:1297-1300

Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ. 2001;322:1357-60.

Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707-13

Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30:231-6.

Klein R, Moghadam-Kia S, Taylor L, Coley C, Okawa J, LoMonico J et al. Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol. 2011;64:849-58.

Sampogna F, Tabolli S, Mastroeni S, Di Pietro C, Fortes C, Abeni D et al. Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology. 2007;215:341-7.

Jones-Caballero M, Chren M, Soler B, Pedrosa E, Peñas P. Quality of life in mild-to-moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatology Venereol. 2007;21:219-26.

Sampogna F, Picardi A, Chren M, Melchi CF, Pasquini P, Masini C et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004; 66: 620-624.




How to Cite

Akbar TM, Nabi H, Saqib MA, Aftab H, Khalil H, Khakwani S, Sahi IR. Use of Skindex-29 to assess quality of life in patients with port-wine stain. J Pak Assoc Dermatol [Internet]. 2018Dec.13 [cited 2024Jun.24];28(2):157-62. Available from:



Original Articles

Most read articles by the same author(s)